Hillhurst Biopharmaceuticals Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.9M

  • Investors
  • 9

Hillhurst Biopharmaceuticals General Information

Description

Developer of novel liquid therapeutic gases designed to treat patients with sickle cell disease and other serious conditions. The company's platform enables the oral delivery of low-dose carbon monoxide and other therapeutic gases, managing acute pain and supporting organ transplantation, enabling healthcare providers to address challenges of inhaled gas therapies by ensuring accurate dosing, safety, and convenience without the risks of unwanted inhalation or environmental contamination.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 117C
  • San Diego, CA 92109
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3030 Bunker Hill Street
  • Suite 117C
  • San Diego, CA 92109
  • United States

Hillhurst Biopharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hillhurst Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 28-Mar-2025 $1.9M Completed Clinical Trials - General
10. Seed Round 25-Sep-2023 Completed Clinical Trials - General
9. Grant 20-Sep-2023 Completed Startup
8. Accelerator/Incubator Completed Startup
7. Grant 01-Jan-2021 Completed Startup
6. Grant 16-May-2020 Completed Startup
5. Grant 01-Jan-2020 Completed Startup
4. Accelerator/Incubator 06-Nov-2018 Completed Startup
3. Grant 01-Jan-2018 $2.2M Completed Startup
2. Grant 01-Jan-2016 $1.8M Completed Startup
To view Hillhurst Biopharmaceuticals’s complete valuation and funding history, request access »

Hillhurst Biopharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Hillhurst Biopharmaceuticals’s complete cap table history, request access »

Hillhurst Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel liquid therapeutic gases designed to treat patients with sickle cell disease and other serious condit
Drug Discovery
San Diego, CA
9 As of 2024

New York, NY
 

Barcelona, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hillhurst Biopharmaceuticals Competitors (13)

One of Hillhurst Biopharmaceuticals’s 13 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Prevail Therapeutics Formerly VC-backed New York, NY
Cardurion Venture Capital-Backed Burlington, MA
You’re viewing 5 of 13 competitors. Get the full list »

Hillhurst Biopharmaceuticals Patents

Hillhurst Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025155909-A1 Solution of nitrous oxide for the treatment of disease Pending 19-Jan-2024
US-20230277583-A1 Enteral carbon monoxide for the prevention and treatment of ocular diseases Pending 04-Mar-2022

Hillhurst Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hillhurst Biopharmaceuticals Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Eye Institute Government
Friedman BioVentures Venture Capital Minority
Octane (California) Accelerator/Incubator
National Institute of General Medical Sciences Government
National Heart, Lung, and Blood Institute Government
You’re viewing 5 of 9 investors. Get the full list »

Hillhurst Biopharmaceuticals FAQs

  • When was Hillhurst Biopharmaceuticals founded?

    Hillhurst Biopharmaceuticals was founded in 2012.

  • Where is Hillhurst Biopharmaceuticals headquartered?

    Hillhurst Biopharmaceuticals is headquartered in San Diego, CA.

  • What is the size of Hillhurst Biopharmaceuticals?

    Hillhurst Biopharmaceuticals has 9 total employees.

  • What industry is Hillhurst Biopharmaceuticals in?

    Hillhurst Biopharmaceuticals’s primary industry is Drug Discovery.

  • Is Hillhurst Biopharmaceuticals a private or public company?

    Hillhurst Biopharmaceuticals is a Private company.

  • What is Hillhurst Biopharmaceuticals’s current revenue?

    The current revenue for Hillhurst Biopharmaceuticals is .

  • How much funding has Hillhurst Biopharmaceuticals raised over time?

    Hillhurst Biopharmaceuticals has raised $1.84M.

  • Who are Hillhurst Biopharmaceuticals’s investors?

    National Eye Institute, Friedman BioVentures, Octane (California), National Institute of General Medical Sciences, and National Heart, Lung, and Blood Institute are 5 of 9 investors who have invested in Hillhurst Biopharmaceuticals.

  • Who are Hillhurst Biopharmaceuticals’s competitors?

    Volastra, Ona Therapeutics, Gesynta Pharma, Prevail Therapeutics, and Cardurion are some of the 13 competitors of Hillhurst Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process